Altimmune Receives Award from U.S. Department of Defense to Fund Phase 1/2 Clinical Trial of T-COVID™ in Outpatients with Early COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| iShares Diversified Alternatives Trust (NASDAQ: ALT) | Delayed: 2.23 +0.03 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.20 | 52 Week High | $54.24 | |||
| Open | $2.22 | 52 Week Low | $48.35 | |||
| Day High | $2.26 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $0.00 | |||
| Volume | 1,790,592 | |||||
